Tamaoki J, Kondo M, Takeuchi S, Takemura H, Nagai A
First Department of Medicine, Tokyo Women's Medical College, Tokyo, Japan.
Am J Respir Cell Mol Biol. 1998 Aug;19(2):293-9. doi: 10.1165/ajrcmb.19.2.3134.
Arginine vasopressin (AVP) has recently been shown to exist in and to be released from airway epithelial cells, but the physiologic role of this hormone in airway epithelial function is unknown. To determine whether AVP affects ciliary motility, and if so, to elucidate the mechanism of action and the subtype of AVP receptors involved, we measured ciliary beat frequency (CBF) and the intracellular Ca2+ concentration ([Ca2+]i) of cultured rabbit tracheal epithelium with a photoelectric method and the fura-2 fluorescence method, respectively. Addition of AVP caused a rapid increase in CBF, followed by a decline and a subsequent sustained response. The ciliary stimulatory action was dose dependent, the maximal peak increase from the baseline CBF being 20.6 +/- 4.7% (mean +/- SE, P < 0.001), and this effect was reduced to 5.9 +/- 2. 0% by the V1 receptor antagonist OPC-21268 (P < 0.01), but not by the V2 receptor antagonist OPC-31260. The AVP-induced increase in CBF was not altered by the protein kinase A (PKA) inhibitor Rp-adenosine-3',5'-cyclic monophosphorothioate triethylamine (Rp-cAMPS) or by Ca2+-free solution containing ethylene glycol-bis-(beta-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA), but was abolished by pretreatment with thapsigargin. Exposure of cells to AVP elicited a transient increase in [Ca2+]i, an effect that was likewise abolished by thapsigargin. The rank-order potency of AVP analogues to increase [Ca2+]i was AVP = [deamino1, D-3-(pyridyl) Ala2-Arg8] vasopressin (DP-VP), a specific V1b receptor agonist > [Phe2, Ile3, Orn8] vasopressin (PO-VT), a V1a agonist > 1-desamino-8-D-arginine vasopressin (dDAVP), a V2 agonist. Moreover, OPC-21268 greatly attenuated the action of AVP, whereas OPC-31260 was without effect. These results suggest that AVP stimulates ciliary motility of rabbit tracheal epithelium through mobilization of Ca2+ from thapsigargin-sensitive stores, and that this effect may be mediated by V1b receptors.
精氨酸加压素(AVP)最近被证明存在于气道上皮细胞中并可从该细胞中释放出来,但这种激素在气道上皮功能中的生理作用尚不清楚。为了确定AVP是否影响纤毛运动,如果有影响,则阐明其作用机制以及所涉及的AVP受体亚型,我们分别采用光电法和fura-2荧光法测量了培养的兔气管上皮细胞的纤毛搏动频率(CBF)和细胞内钙离子浓度([Ca2+]i)。加入AVP后,CBF迅速增加,随后下降并出现持续反应。纤毛刺激作用呈剂量依赖性,相对于基线CBF的最大峰值增加为20.6±4.7%(平均值±标准误,P<0.001),V1受体拮抗剂OPC-21268可将这种效应降低至5.9±2.0%(P<0.01),而V2受体拮抗剂OPC-31260则无此作用。蛋白激酶A(PKA)抑制剂Rp-腺苷-3',5'-环磷酸硫代三乙胺(Rp-cAMPS)或含有乙二醇双(β-氨基乙醚)N,N,N',N'-四乙酸(EGTA)的无钙溶液不会改变AVP诱导的CBF增加,但毒胡萝卜素预处理可消除这种增加。细胞暴露于AVP会引起[Ca2+]i的短暂增加,毒胡萝卜素同样可消除这种效应。AVP类似物增加[Ca2+]i的效价顺序为AVP = [脱氨基1,D-3-(吡啶基)丙氨酸2-精氨酸8]加压素(DP-VP),一种特异性V1b受体激动剂>[苯丙氨酸2,异亮氨酸3,鸟氨酸8]加压素(PO-VT),一种V1a激动剂>1-脱氨基-8-D-精氨酸加压素(dDAVP),一种V2激动剂。此外,OPC-21268可大大减弱AVP的作用,而OPC-31260则无作用。这些结果表明,AVP通过从毒胡萝卜素敏感储存库中动员Ca2+来刺激兔气管上皮细胞的纤毛运动,并且这种效应可能由Vib受体介导。